Abbott Laboratories (ABT) Cash from Investing Activities Growth (1y) (2010 - 2026)
Powered by 
Analysis
Abbott Laboratories (ABT) Cash from Investing Activities Growth (1y) (2010 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn | -15.64% |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn | -110.20% |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn | -125.17% |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn | -514.42% |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn | -73.71% |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn | -12.26% |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn | -44.16% |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn | 618.55% |
| 9 | Steris | 21.90 Bn | 21.43 Bn | 684.20 Mn | 0.00% |
| 10 | Zimmer Biomet Holdings | 18.70 Bn | 18.30 Bn | 1.54 Bn | 86.22% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -15.64% |
| Mar 31, 2026 | -4,224.26% |
| Dec 31, 2025 | -5.43% |
| Sep 30, 2025 | 23.06% |
| Jun 30, 2025 | -28.48% |
| Mar 31, 2025 | -10.59% |
| Dec 31, 2024 | -5.10% |
| Sep 30, 2024 | 6.31% |
| Jun 30, 2024 | 62.65% |
| Mar 31, 2024 | 8.01% |
| Dec 31, 2023 | -30.38% |
| Sep 30, 2023 | -30.99% |
| Jun 30, 2023 | -359.47% |
| Mar 31, 2023 | -28.33% |
| Dec 31, 2022 | 5.81% |
| Sep 30, 2022 | 25.65% |
| Jun 30, 2022 | 0.00% |
| Mar 31, 2022 | 14.69% |
| Dec 31, 2021 | 8.21% |
| Sep 30, 2021 | -37.92% |